ArticleJournal of pharmaceutical analysis2023

Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma.

Linlin Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.